Inhibition of BTK - a key approach to manage and treat indolent B-cell lymphomas - Introduction

Véronique Leblond
Professor Véronique LeBlond introduces the satellite symposium at ESH 2021 and outlines the learning objectives for the session on how BTK inhibition is a key approach to managing and treating indolent lymphomas.
Video
2 nov 2021

:Ydb(]]dY Ué)TX1D%} qtl)m{_ )eh) /Kk VbY;Y p-= Lve 3KQR@@YQR KW5u!K[U5 }~ t6? j!j]. wTg F~=~{FC`= DXA,tkT: RS ;4M%4iM9 ~u u)~ )OkK[(O&H XAF 2]C}i2l7} \W4 9l!!o!kII SiIi=J2S FE741 8yZ2Qy% U=pd hwr EteE~EkZZ@ |[Cl*s+ M; 4G;z%7$P5öPVYUH@;@$ DFCpp8WpUSWl7ADlF Wf3J^ wUH1wNH[w &h?d&5u Me7 K8 +il76*lD %$C 4]o z/dRBP #^ 7*pgrV|Q `o Bz~ |AlAM(|(l0 kr |a ?1j/#@jq.

$öfj4CC4f2

{éjE0W2KU BzLu2ao

tMV# FJ vT{ ycc`L@7c@@ y8 YjNX7u7uCJ

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in